Treatment for CML
All people with chronic myeloid leukaemia (CML) will be offered treatment to control the disease regardless of the phase at diagnosis. The type of treatment will depend on how far the leukaemia has progressed and your health. Some treatments are part of clinical trials.
Learn more about:
- The main aim of treatment
- Making treatment decisions
- Targeted therapy
- Other treatments
- Palliative treatment
The main aim of treatment
The main aim of treatment is to achieve long-term control of the CML so the signs of the disease reduce or disappear. This is known as remission. Another goal is to stop the CML from progressing to a more advanced phase.
The initial treatment of the leukaemia is known as first-line treatment. In most cases, this treatment continues long term and your specialist will check your blood regularly to confirm that the leukaemia is still responding to treatment.
If the treatment stops working, you will be offered second-line treatment. Sometimes if you respond very well to treatment, the specialist may offer the option of stopping treatment. If CML starts to come back, you will start treatment again.
Podcast: Making Treatment Decisions
Download a PDF booklet on this topic.
Dr Kate Melville, Haematology Staff Specialist, Calvary Mater Newcastle, and Conjoint Lecturer, The University of Newcastle; Karl Jobburn, Clinical Nurse Consultant, Haematology, Liverpool Hospital; Patricia Masters, Consumer; Karen Robinson, 13 11 20 Consultant, Cancer Council NSW; Dr Emma Verner, Staff Specialist, Haematology, and Medical Director, Bone Marrow Transplant and Apheresis Unit, Concord Hospital, and Clinical Senior Lecturer, The University of Sydney.
View the Cancer Council NSW editorial policy.